HIV Prevention Clinical Trial
Official title:
Randomized Controlled Trial of a Couples-based Intervention to Increase Testing for HIV Among Heterosexual Couples in Vulindlela, KwaZulu-Natal, South Africa
The prevalence for human immunodeficiency virus (HIV) in South Africa is 18% among 15-49
year old adults and 30% among female antenatal clinic attendees (UNAIDS, 2007), indicating
continuing need for effective HIV prevention. Further, recent studies in sub-Saharan Africa
found 60-94% of new HIV infections are occurring within marriage or co-habiting heterosexual
partnerships (Dunkle et al., 2008). These findings signal the need for HIV prevention
interventions that target couples in South Africa. This study is a randomized controlled
trial of a behavioral intervention to increase HIV testing among couples living in
Vulindlela, South Africa.
The proposed intervention consists of six sessions (one mixed gender group, one single
gender group, and four couples' counseling sessions). Using a randomized controlled trial
(RCT) design with 350 heterosexual couples, we will test the hypothesis that compared with a
one-time mixed-gender group session, the proposed intervention will improve communication,
intimacy and trust necessary for mutual decision-making about behaviours related to sexual
risk behaviour and testing for HIV. Improving couples' ability and motivation to participate
in Couples HIV Testing and Counseling (CHTC) for HIV will in turn lead to reductions in
sexual risk behaviour. Both of these outcomes are necessary and effective strategies to
reduce the risk of HIV transmission within primary partnerships.
This intervention is informed by several qualitative studies conducted in Vulindlela and
Soweto, South Africa via a K08 award from NIH, as well as other funding sources. These
preliminary studies provided insight into the challenges couples face in participating in
CHCT, as well as the skills they need in order to address these barriers. Our experience
conducting both qualitative and quantitative studies with comparable populations (i.e. South
African couples) has also informed the recruitment and retention methods in this
intervention. The proposed study takes advantage of the infrastructure and collaborative
relationships that the PI has developed that have enabled her to implement and conduct
research within these communities.
The specific aims of the project are to test the efficacy of a theory-based and culturally
appropriate couples-based intervention on the following outcomes:
1. Rates of testing for HIV,
2. Sexual risk behaviour for HIV (with primary and any concurrent partners).
In addition we will evaluate the extent to which hypothesized mediating factors (e.g.,
relationship dynamics) explain the major outcomes and the extent to which the intervention
affects these factors.
Ultimately, our goal is to facilitate the outcome that members of partnerships learn their
own and their partner's HIV status. This is a crucial step for effective behavioural risk
reduction, yet it is a relatively uncommon occurrence for partners in Vulindlela, South
Africa. Specifically, mutual disclosure of HIV status accomplishes two important goals.
First, this knowledge can facilitate risk-reduction behaviour within partnerships via
effecting positive changes (e.g., condom use) in sexual behaviour with primary and any
concurrent partners. Second, knowledge of HIV status can increase access to treatment and
care for HIV-positive individuals, as well as reinforce behavioural choices (e.g., limiting
concurrent partners) to stay HIV-negative. As couples are particularly vulnerable for HIV
infection in this context, increasing testing for HIV and reducing likelihood of behavioural
transmission of HIV within partnerships would be a high-impact outcome with the potential to
significantly reduce the impact of HIV in an area already severely affected by the pandemic.
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator)
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03411577 -
Development and Testing of a Jamaican Mother-daughter HIV Risk-reduction Program
|
N/A | |
Active, not recruiting |
NCT03112369 -
Preventing HIV Among Native Americans Through the Treatment PTSD & Substance Use
|
N/A | |
Not yet recruiting |
NCT03642314 -
HIV Self-testing in Implementation PrEP Study
|
N/A | |
Completed |
NCT01810315 -
Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity
|
Phase 1 | |
Completed |
NCT00984971 -
Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet
|
Phase 1 | |
Completed |
NCT00142935 -
Effectiveness of Opiate Replacement Therapy Administered Prior to Release From a Correctional Facility - 1
|
N/A | |
Active, not recruiting |
NCT03255915 -
PrEP-Pod-IVR (TDF-FTC/Placebo IVR 28 Day Crossover Study)
|
Early Phase 1 | |
Completed |
NCT05037513 -
Integrated PrEP Interventions for People Who Inject Drugs in Rural Kentucky
|
N/A | |
Recruiting |
NCT05087680 -
An Acceptance Based PrEP Intervention to Engage Young Black MSM in the South
|
N/A | |
Recruiting |
NCT05804461 -
Optimizing Pre-Exposure Prophylaxis (PrEP) Among Latino Men Who Have Sex With Men (MSM) in Puerto Rico
|
N/A | |
Completed |
NCT03148171 -
Project WERK (Wellness Encouragement Respect Kinship)
|
N/A | |
Completed |
NCT04791007 -
OB-002H Gel Administered Vaginally and Rectally in HIV-1 Seronegative Adults
|
Early Phase 1 | |
Recruiting |
NCT05412433 -
Clinic-based HIV Identification and Prevention Project Using Electronic Resources
|
N/A | |
Active, not recruiting |
NCT03977181 -
The Community PrEP Study to Assess the Acceptance of PrEP Delivered Through CBCT Platforms
|
N/A | |
Recruiting |
NCT05165745 -
Stick2PrEP Cisgender Women and Trans Individuals
|
N/A | |
Completed |
NCT03719053 -
Single Dose Truvada Study
|
Phase 1 | |
Recruiting |
NCT03856580 -
Long-acting Biomedical HIV Prevention in Transgender Women
|
N/A | |
Completed |
NCT02750540 -
Optimization of a Tenofovir Enema for HIV Prevention
|
Phase 1 | |
Completed |
NCT01386294 -
Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection
|
Phase 3 | |
Completed |
NCT00993811 -
The Shang Ring: A Novel Male Circumcision Device for HIV Prevention
|
Phase 1 |